ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 9.50
+0.45 (4.97%)
Jul 28, 2026, 1:09 PM CET
ViroGates Revenue
ViroGates had revenue of 1.30M DKK in the quarter ending March 31, 2026, with 8.40% growth. This brings the company's revenue in the last twelve months to 5.41M, up 10.34% year-over-year. In the year 2025, ViroGates had annual revenue of 5.31M with 8.37% growth.
Revenue (ttm)
5.41M
Revenue Growth
+10.34%
P/S Ratio
9.79
Revenue / Employee
1.29M
Employees
7
Market Cap
88.18M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.31M | 410.00K | 8.37% |
| Dec 31, 2024 | 4.90M | -685.00K | -12.27% |
| Dec 31, 2023 | 5.58M | -4.57M | -45.01% |
| Dec 31, 2022 | 10.15M | 2.50M | 32.59% |
| Dec 31, 2021 | 7.66M | 2.30M | 43.00% |
| Dec 31, 2020 | 5.35M | 1.77M | 49.47% |
| Dec 31, 2019 | 3.58M | 267.00K | 8.05% |
| Dec 31, 2018 | 3.32M | 874.00K | 35.80% |
| Dec 31, 2017 | 2.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 327.80B |
| Coloplast | 28.05B |
| Genmab | 25.29B |
| Demant | 22.97B |
| Gubra | 2.64B |
| Scandinavian Medical Solutions | 214.99M |
| BioPorto | 40.29M |
| Stenocare | 9.24M |
ViroGates News
- 2 months ago - ViroGates Quarterly report: Q1 2026 - Filings
- 4 months ago - ViroGates Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - ViroGates Annual report: Q4 2025 - Filings
- 9 months ago - ViroGates Earnings Call Transcript: Q3 2025 - Transcripts
- 9 months ago - ViroGates Quarterly report: Q3 2025 - Filings
- 1 year ago - ViroGates Quarterly report: Q2 2025 - Filings